Congenica

📍 Cambridge, United Kingdom🗓 Founded 2014👥 97 employees💰 Last funded Oct 2019
Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. We drive Precision Medicine and help reduce the burden on healthcare systems by delivering automated analysis, diagnosis and treatment solutions to healthcare providers and patients worldwide. Congenica’s Platform is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive for both rare diseases and somatic and inherited cancer, and is uniquely placed to drive ubiquitous use of complex data in routine clinical care. Our products and services are consolidated on one single scalable, automated analysis and diagnostic platform that encompasses inherited disease, somatic cancer, pharma insights and pathogen surveillance. Congenica was founded based on pioneering work at the Wellcome Trust Sanger Institute and the UK NHS. We are the exclusive clinical decision support partner for the NHS Genomic Medicine Service and have a global footprint supporting leading international laboratories, academic medical centres, hospitals and biopharmaceutical companies.
5
Total investors
3
Early stage
2
Mid stage
0
Late stage
2014
Founded
Investor geography1 country
United Kingdom
5
Investor activity2015–2019 · investors recorded per year
201532018120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Congenica?
Congenica has 5 investors on record on gritt.io, including 3 early-stage backers, 2 mid-stage.
When did Congenica last raise funding?
The most recent investment in Congenica recorded on gritt.io was in October 2019.
When was Congenica founded?
Congenica was founded in 2014.
What industry is Congenica in?
Congenica operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Congenica based?
Congenica is headquartered in Cambridge, United Kingdom.